Literature DB >> 21124721

Time for new recommendations on cotrimoxazole prophylaxis for HIV-exposed infants in developing countries?

Anna Coutsoudis1, Hoosen M Coovadia, Gurpreet Kindra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21124721      PMCID： PMC2995188          DOI： 10.2471/BLT.10.076422

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  9 in total

1.  Prevention of breast milk transmission of HIV: the time is now.

Authors:  Lynne M Mofenson
Journal:  J Acquir Immune Defic Syndr       Date:  2009-11-01       Impact factor: 3.731

2.  Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family members.

Authors:  Jonathan Mermin; John Lule; John Paul Ekwaru; Robert Downing; Peter Hughes; Rebecca Bunnell; Samuel Malamba; Ray Ransom; Frank Kaharuza; Alex Coutinho; Aminah Kigozi; Robert Quick
Journal:  AIDS       Date:  2005-07-01       Impact factor: 4.177

3.  Routinely available cotrimoxazole prophylaxis and occurrence of respiratory and diarrhoeal morbidity in infants born to HIV-infected mothers in South Africa.

Authors:  A Coutsoudis; K Pillay; E Spooner; H M Coovadia; L Pembrey; M-L Newell
Journal:  S Afr Med J       Date:  2005-05

4.  Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era.

Authors:  J N Martin; D A Rose; W K Hadley; F Perdreau-Remington; P K Lam; J L Gerberding
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

5.  Adverse reactions to trimethoprim-sulfamethoxazole among children with human immunodeficiency virus infection.

Authors:  M J Rieder; S M King; S Read
Journal:  Pediatr Infect Dis J       Date:  1997-11       Impact factor: 2.129

6.  Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.

Authors:  C Chintu; G J Bhat; A S Walker; V Mulenga; F Sinyinza; K Lishimpi; L Farrelly; N Kaganson; A Zumla; S H Gillespie; A J Nunn; D M Gibb
Journal:  Lancet       Date:  2004 Nov 20-26       Impact factor: 79.321

Review 7.  Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection.

Authors:  Christopher J Gill; Lora L Sabin; Joseph Tham; Davidson H Hamer
Journal:  Bull World Health Organ       Date:  2004-04       Impact factor: 9.408

8.  Hospitalization and mortality among primarily nonbreastfed children during a large outbreak of diarrhea and malnutrition in Botswana, 2006.

Authors:  Tracy L Creek; Andrea Kim; Lydia Lu; Anna Bowen; Japhter Masunge; Wences Arvelo; Molly Smit; Ondrej Mach; Keitumetse Legwaila; Catherine Motswere; Laurel Zaks; Thomas Finkbeiner; Laura Povinelli; Maruping Maruping; Gibson Ngwaru; Goitebetswe Tebele; Cheryl Bopp; Nancy Puhr; Stephanie P Johnston; Alexandre J Dasilva; Caryn Bern; R S Beard; Margarett K Davis
Journal:  J Acquir Immune Defic Syndr       Date:  2010-01       Impact factor: 3.731

Review 9.  Breast milk as the gold standard for protective nutrients.

Authors:  Allan Walker
Journal:  J Pediatr       Date:  2010-02       Impact factor: 4.406
  9 in total
  10 in total

1.  Extended prophylaxis with nevirapine and cotrimoxazole among HIV-exposed uninfected infants is well tolerated.

Authors:  Jim Aizire; Mary Glenn Fowler; Jing Wang; Avinash K Shetty; Lynda Stranix-Chibanda; Moreen Kamateeka; Elizabeth R Brown; Steve G Bolton; Philippa M Musoke; Hoosen Coovadia
Journal:  AIDS       Date:  2012-01-28       Impact factor: 4.177

2.  Management of diarrhea in HIV-affected infants and children.

Authors:  Patricia B Pavlinac; Kirkby D Tickell; Judd L Walson
Journal:  Expert Rev Anti Infect Ther       Date:  2014-11-11       Impact factor: 5.091

3.  Health outcomes of HIV-exposed uninfected African infants.

Authors:  Athena P Kourtis; Jeffrey Wiener; Dumbani Kayira; Charles Chasela; Sascha R Ellington; Lisa Hyde; Mina Hosseinipour; Charles van der Horst; Denise J Jamieson
Journal:  AIDS       Date:  2013-03-13       Impact factor: 4.177

4.  HIV-exposed infants: rethinking care for a lifelong condition.

Authors:  Nandita Sugandhi; Jessica Rodrigues; Maria Kim; Saeed Ahmed; Anouk Amzel; Mike Tolle; Eric J Dziuban; Scott E Kellerman; Emilia Rivadeneira
Journal:  AIDS       Date:  2013-11       Impact factor: 4.177

5.  Peripheral blood mononuclear cell transcriptomes reveal an over-representation of down-regulated genes associated with immunity in HIV-exposed uninfected infants.

Authors:  Zaneta D Musimbi; Martin K Rono; James R Otieno; Nelson Kibinge; Lynette Isabella Ochola-Oyier; Etienne Pierre de Villiers; Eunice W Nduati
Journal:  Sci Rep       Date:  2019-12-02       Impact factor: 4.379

6.  Pneumocystis pneumonia in South African children diagnosed by molecular methods.

Authors:  Brenda M Morrow; Catherine M Samuel; Marco Zampoli; Andrew Whitelaw; Heather J Zar
Journal:  BMC Res Notes       Date:  2014-01-10

7.  Randomised controlled trial testing the effect of cotrimoxazole prophylaxis on morbidity and mortality outcomes in breastfed HIV-exposed uninfected infants: study protocol.

Authors:  Anna Coutsoudis; Brodie Daniels; Eshia Moodley-Govender; Noluthando Ngomane; Linda Zako; Elizabeth Spooner; Photini Kiepiela; Shabashini Reddy; Louise Kuhn; Gita Ramjee
Journal:  BMJ Open       Date:  2016-07-12       Impact factor: 2.692

8.  The prevalence and clinical characteristics of pertussis-associated pneumonia among infants in Botswana.

Authors:  Bahaa Abu-Raya; David M Goldfarb; Marek Smieja; Kathy Luinstra; Melissa Richard-Greenblatt; Andrew P Steenhoff; Kristen A Feemster; Tonya Arscott-Mills; Coleen K Cunningham; Samir S Shah; Mohamed Zaakir Patel; Matthew S Kelly; Manish Sadarangani
Journal:  BMC Pediatr       Date:  2019-11-16       Impact factor: 2.125

9.  Cotrimoxazole prophylaxis and risk of severe anemia or severe neutropenia in HAART-exposed, HIV-uninfected infants.

Authors:  Scott Dryden-Peterson; Oluwemimo Jayeoba; Michael D Hughes; Haruna Jibril; Kenneth McIntosh; Taolo A Modise; Aida Asmelash; Kathleen M Powis; Max Essex; Roger L Shapiro; Shahin Lockman
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

10.  The activity of commercial antimicrobials, and essential oils and ethanolic extracts of Olea europaea on Streptococcus agalactiae isolated from pregnant women.

Authors:  Munyaradzi Mukesi; Benson C Iweriebor; Larry C Obi; Uchechukwu U Nwodo; Sylvester R Moyo; Anthony I Okoh
Journal:  BMC Complement Altern Med       Date:  2019-01-30       Impact factor: 3.659
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.